Search & Filter

Red states are challenging the legality of mail order abortion pills by taking the issue to the Supreme Court. The outcome could impact abortion access policies in states including Louisiana if similar restrictions are pursued locally.

Louisiana is challenging the FDA's 2023 policy allowing mail-order dispensing of the abortion drug mifepristone, seeking a stay to prevent nationwide online availability even in states where abortion is legal. The state's lawsuit argues the FDA's updated regulations rely on inaccurate data and contribute to illegal mail-order abortions, with the case currently before the Fifth Circuit Court of Appeals and likely to be appealed to the Supreme Court.